MEDNAX Inc at Jefferies Healthcare Conference Transcript

Jun 04, 2019 / 06:30PM GMT
Jason Michael Plagman - Jefferies LLC, Research Division - Equity Associate

We have Stephen Farber, company CFO; and Head of IR, Charlie Lynch. So what we'd like to kind of open with is Stephen, you've been with MEDNAX for about 9 months now. What things have gone better than expected thus far? And what would you say have been some of the challenges that you're focused on right now and kind of working through those over the next year or 2?

Questions and Answers:

Stephen D. Farber - MEDNAX, Inc. - Executive VP & CFO

Sure. I guess the way I think about it is, MEDNAX has been working through -- like I've been CFO, I guess, for 2 quarters. I was here for a little while before first that part of the role got turned over, and MEDNAX has been working through a number of challenges, really, I guess, probably since the beginning of '17 or something right around that.

And so I came in when the company was already 6, 7 quarters into working through a number of things, and I guess, I feel like we're starting to get traction on a number of things that we
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot